Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...
The effect of glucagon-like peptide 1 receptor agonists on patients with joint infections was a popular topic at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback